Literature DB >> 16334143

Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation.

Yasuyuki Hasegawa1, Katsuyuki Tomita, Kiyoshi Hashimoto, Yasushi Shigeoka, Masanari Watanabe, Akira Yamasaki, Eiji Shimizu.   

Abstract

The case of a 48-year-old man with primary nonseminomatous embryonal carcinoma at the posterior mediastinum is described. The patient displayed extremely high plasma levels of Des-gamma-carboxy prothrombin (PIVKA-II) (4040 mAU/ml). Ultrasonography and dynamic computed tomography ruled out hepatocellular carcinoma (HCC) or liver metastasis. After preoperative systemic chemotherapy, total tumor resection was performed. Postoperatively, the plasma levels of PIVKA-II returned to within the normal range (24 mAU/ml). An immnohistochemical study using anti-PIVKA-II monoclonal antibody revealed the cytoplasmic expression of PIVK4-II in the carcinoma cells. These results indicate that tumor cells, which are manifested as hepatoid differentiation, may produce PIVKA-II. This case seems to be the first case reported in which PIVKA-II was produced by nonseminomatous mediastinal embryonal carcinoma without HCC or liver metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334143

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Primary colon cancer with a high serum PIVKA-II level.

Authors:  Kazuya Kato; Yoshiaki Iwasaki; Masahiko Taniguchi; Kazuhiko Onodera; Minoru Matsuda; Takako Kawakami; Mineko Higuchi; Kimitaka Kato; Yurina Kato; Hiroyuki Furukawa
Journal:  Int J Surg Case Rep       Date:  2014-12-04

2.  Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature.

Authors:  Guiyuan Zhang; Chunyong Wen; Bin Chen; Haitao Dai; Run Lin; Yonghui Huang; Xianhong Xiang
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.